Annual FCF
-$82.68 M
-$46.85 M-130.78%
December 31, 2023
Summary
- As of February 7, 2025, STOK annual free cash flow is -$82.68 million, with the most recent change of -$46.85 million (-130.78%) on December 31, 2023.
- During the last 3 years, STOK annual FCF has fallen by -$39.41 million (-91.08%).
- STOK annual FCF is now -1404.15% below its all-time high of -$5.50 million, reached on December 31, 2017.
Performance
STOK Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$21.72 M
-$4.20 M-23.94%
September 30, 2024
Summary
- As of February 7, 2025, STOK quarterly free cash flow is -$21.72 million, with the most recent change of -$4.20 million (-23.94%) on September 30, 2024.
- Over the past year, STOK quarterly FCF has dropped by -$4.07 million (-23.08%).
- STOK quarterly FCF is now -168.62% below its all-time high of $31.65 million, reached on March 31, 2022.
Performance
STOK Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$84.70 M
-$4.07 M-5.05%
September 30, 2024
Summary
- As of February 7, 2025, STOK TTM free cash flow is -$84.70 million, with the most recent change of -$4.07 million (-5.05%) on September 30, 2024.
- Over the past year, STOK TTM FCF has dropped by -$110.00 thousand (-0.13%).
- STOK TTM FCF is now -4103.33% below its all-time high of -$2.02 million, reached on March 31, 2018.
Performance
STOK TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
STOK Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -130.8% | -23.1% | -0.1% |
| 3 y3 years | -91.1% | -23.1% | -0.1% |
| 5 y5 years | -594.9% | -23.1% | -0.1% |
STOK Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -130.8% | at low | -168.6% | +11.6% | -425.5% | +7.0% |
| 5 y | 5-year | -152.9% | at low | -168.6% | +11.6% | -425.5% | +7.0% |
| alltime | all time | -1404.2% | at low | -168.6% | +11.6% | -4103.3% | +7.0% |
Stoke Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$21.72 M(+23.9%) | -$84.70 M(+5.1%) |
| Jun 2024 | - | -$17.52 M(-28.7%) | -$80.62 M(-6.0%) |
| Mar 2024 | - | -$24.58 M(+17.7%) | -$85.74 M(+3.7%) |
| Dec 2023 | -$82.68 M(+130.8%) | -$20.88 M(+18.3%) | -$82.68 M(-2.3%) |
| Sep 2023 | - | -$17.64 M(-22.1%) | -$84.59 M(-7.1%) |
| Jun 2023 | - | -$22.64 M(+5.2%) | -$91.03 M(+2.3%) |
| Mar 2023 | - | -$21.52 M(-5.5%) | -$89.00 M(+148.4%) |
| Dec 2022 | -$35.83 M(-47.4%) | -$22.78 M(-5.4%) | -$35.83 M(+21.4%) |
| Sep 2022 | - | -$24.09 M(+16.9%) | -$29.51 M(+44.8%) |
| Jun 2022 | - | -$20.61 M(-165.1%) | -$20.38 M(+26.4%) |
| Mar 2022 | - | $31.65 M(-292.3%) | -$16.12 M(-76.3%) |
| Dec 2021 | -$68.11 M | -$16.46 M(+10.1%) | -$68.11 M(+8.7%) |
| Sep 2021 | - | -$14.96 M(-8.5%) | -$62.67 M(+6.5%) |
| Jun 2021 | - | -$16.35 M(-19.6%) | -$58.85 M(+12.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$20.34 M(+84.6%) | -$52.23 M(+20.7%) |
| Dec 2020 | -$43.27 M(+32.4%) | -$11.02 M(-1.1%) | -$43.27 M(+0.6%) |
| Sep 2020 | - | -$11.14 M(+14.5%) | -$43.02 M(+6.2%) |
| Jun 2020 | - | -$9.73 M(-14.5%) | -$40.51 M(+8.2%) |
| Mar 2020 | - | -$11.38 M(+5.7%) | -$37.45 M(+14.6%) |
| Dec 2019 | -$32.69 M(+174.7%) | -$10.77 M(+24.8%) | -$32.69 M(+28.1%) |
| Sep 2019 | - | -$8.63 M(+29.5%) | -$25.53 M(+24.8%) |
| Jun 2019 | - | -$6.67 M(+0.6%) | -$20.45 M(+23.9%) |
| Mar 2019 | - | -$6.62 M(+83.6%) | -$16.51 M(+38.7%) |
| Dec 2018 | -$11.90 M(+116.5%) | -$3.61 M(+1.4%) | -$11.90 M(+43.5%) |
| Sep 2018 | - | -$3.56 M(+30.8%) | -$8.29 M(+75.1%) |
| Jun 2018 | - | -$2.72 M(+34.9%) | -$4.73 M(+134.9%) |
| Mar 2018 | - | -$2.02 M | -$2.02 M |
| Dec 2017 | -$5.50 M | - | - |
FAQ
- What is Stoke Therapeutics annual free cash flow?
- What is the all time high annual FCF for Stoke Therapeutics?
- What is Stoke Therapeutics annual FCF year-on-year change?
- What is Stoke Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Stoke Therapeutics?
- What is Stoke Therapeutics quarterly FCF year-on-year change?
- What is Stoke Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Stoke Therapeutics?
- What is Stoke Therapeutics TTM FCF year-on-year change?
What is Stoke Therapeutics annual free cash flow?
The current annual FCF of STOK is -$82.68 M
What is the all time high annual FCF for Stoke Therapeutics?
Stoke Therapeutics all-time high annual free cash flow is -$5.50 M
What is Stoke Therapeutics annual FCF year-on-year change?
Over the past year, STOK annual free cash flow has changed by -$46.85 M (-130.78%)
What is Stoke Therapeutics quarterly free cash flow?
The current quarterly FCF of STOK is -$21.72 M
What is the all time high quarterly FCF for Stoke Therapeutics?
Stoke Therapeutics all-time high quarterly free cash flow is $31.65 M
What is Stoke Therapeutics quarterly FCF year-on-year change?
Over the past year, STOK quarterly free cash flow has changed by -$4.07 M (-23.08%)
What is Stoke Therapeutics TTM free cash flow?
The current TTM FCF of STOK is -$84.70 M
What is the all time high TTM FCF for Stoke Therapeutics?
Stoke Therapeutics all-time high TTM free cash flow is -$2.02 M
What is Stoke Therapeutics TTM FCF year-on-year change?
Over the past year, STOK TTM free cash flow has changed by -$110.00 K (-0.13%)